Haemolytic-uraemic syndrome after tacrolimus rescue therapy for cortisone-resistant rejection.
D058186:Acute Kidney Injury / Q000628:therapy*; D000284:Administration, Oral; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects*; D014184:Transplantation, Homologous